
A living drug manages to eliminate tumors in mice with pancreatic, ovarian and kidney cancer
The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of leukemias and lymphomas

The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of leukemias and lymphomas